Waters Corporation

Waters Corporation is an American company headquartered in Milford, Massachusetts, that specializes in providing analytical instruments, software, and services. Its core business revolves around chromatography, mass spectrometry, laboratory informatics, and rheometry. The company's mission is centered on customer success, aiming to create business advantages for laboratory-dependent organizations through sustainable scientific innovation, thereby advancing areas such as healthcare delivery, environmental management, food safety, water quality, consumer products, and high-value chemicals.

Waters Corporation offers a comprehensive portfolio of products, including ACQUITY UPLC Systems, Xevo mass spectrometry systems, Alliance HPLC systems, and Empower chromatography software. Additionally, its TA Instruments division provides thermal analysis and rheometry instruments. These technologies serve diverse market segments, including life sciences, materials science, food and beverage, environmental analysis, biopharma, chemical, clinical research, diagnostics, and forensics.

Led by President and CEO Udit Batra, who was appointed in September 2020, Waters Corporation recently completed a significant merger on February 9, 2026, with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company. This strategic move aims to establish Waters as a global leader in life sciences and diagnostics. The company has also introduced new products, such as the ARES-G3 Rheometer in March 2026 and the omniDAWN Multi-Angle Light Scattering (MALS) Photometer in April 2026, and announced FDA clearance for an at-home cervical cancer screening tool in April 2026. Waters' analytical instruments are widely regarded as a gold standard in various applications, particularly in biopharmaceutical LC-MS.